TSX:AGI
TSX:AGIMetals and Mining

Alamos Gold (TSX:AGI) Valuation After Record Revenues And Production Miss Driven By Severe Winter Weather

Alamos Gold (TSX:AGI) has drawn attention after reporting record quarterly and annual revenues, alongside lower-than-planned Q4 and full-year 2025 gold production, with weather-related disruptions also coinciding with a sharp share price pullback. See our latest analysis for Alamos Gold. Those record revenue figures come after a strong run, with the share price at CA$54.14 today and a 1 year total shareholder return of 92.43% and 5 year total shareholder return of roughly 4.6x. However,...
TWSE:2330
TWSE:2330Semiconductor

Is It Too Late To Consider Taiwan Semiconductor Manufacturing (TWSE:2330) After Its Strong Rally?

If you have been wondering whether Taiwan Semiconductor Manufacturing is still reasonably priced after its strong run, this article will walk you through what the current share price could mean for value focused investors. The stock last closed at NT$1,740, with returns of 3.6% over the past 7 days, 21.7% over 30 days, 9.8% year to date, 57.9% over 1 year, 265.1% over 3 years and 194.3% over 5 years, so it is understandable if you are questioning what is already priced in. Recent coverage...
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Rigel Pharmaceuticals (RIGL) Valuation After New REZLIDHIA Trial And 2026 Revenue Guidance

Rigel Pharmaceuticals (RIGL) has drawn fresh attention after launching a Phase 1b/2 trial combining REZLIDHIA with other therapies for acute myeloid leukemia and issuing full year 2026 revenue guidance of US$275 million to US$290 million. See our latest analysis for Rigel Pharmaceuticals. Despite the latest clinical update and 2026 revenue guidance, Rigel Pharmaceuticals’ recent share price performance has cooled, with a 7 day share price return of 8.23% and a 30 day share price return of...
NYSE:MWA
NYSE:MWAMachinery

A Look At Mueller Water Products (MWA) Valuation After Passing A Peter Lynch GARP Investment Screen

Mueller Water Products triggered by GARP screen Mueller Water Products (MWA) recently passed a Peter Lynch Growth at a Reasonable Price screen, highlighting a mix of earnings growth, PEG based valuation, financial strength, and return on equity that has caught investor attention. See our latest analysis for Mueller Water Products. The GARP trigger comes after a steady run, with a 7 day share price return of 4.24% and a 30 day share price return of 6.39% at a latest close of $26.31, while 1...
NYSE:BBWI
NYSE:BBWISpecialty Retail

Did Securities Lawsuit Over Growth Missteps Just Shift Bath & Body Works' (BBWI) Investment Narrative?

Glancy Prongay & Murray LLP has filed a securities class action in the Southern District of Ohio alleging Bath & Body Works misled investors between June 4, 2024 and November 19, 2025, following sharp year-over-year declines in earnings, multiple guidance cuts, and acknowledgment that recent growth initiatives failed to expand its customer base. The lawsuit arrives as Bath & Body Works is both closing more mall locations and refreshing product lines, underscoring the tension between...
NYSE:CAVA
NYSE:CAVAHospitality

Is Cava Group (CAVA) Pricing In Too Much Growth After Its Recent Share Price Rebound

If you are wondering whether CAVA Group at around US$72 a share is a bargain or already pricing in a lot of optimism, you are not alone. The stock has returned 1.7% over the last 7 days and 35.7% over the last 30 days, while the year to date return is 19.1% and the 1 year return is a 39.0% decline. Recent coverage has focused on CAVA Group as a newly public fast casual restaurant brand with strong consumer awareness, with attention on how quickly it is expanding its store base and scaling...
NYSE:CI
NYSE:CIHealthcare

Will Cigna's (CI) New Veteran Health Initiatives Reshape Its Margin-Focused Investment Narrative?

Earlier this month, Hankook Tire America Corp. opened the Hankook Tire Clinic Powered by Evernorth at its Clarksville, Tennessee plant, while The Cigna Group also renewed its multiyear sponsorship of Achilles International’s Freedom Team with nearly US$1.00 million committed over three years. Together, these initiatives highlight Cigna’s emphasis on integrated health services and visible community investment in veterans and athletes with disabilities, reinforcing its broader health-focused...